https://backend.otcmarkets.com/otcapi/company/fina
https://backend.otcmarkets.com/otcapi/company...72/content
During the quarter ending January 31, 2013, a direct investment in the Company was made in exchange for 62,500,000 restricted common shares pursuant to a Private Placement Memorandum. These shares were issued as restricted for a period of one year. Additionally, 13,600 preferred B shares were converted into 6,120,000 common shares. As of January 31, 2013 there were 1,157,757,196 common shares at .00001 par of which 149,887,300 were restricted, 99,202,300 series A preferred shares issued at .00001 par, 18,984,035 series B preferred shares issued at .00001 par and no serried C preferred shares issued.
During the quarter ending April 30, 2013, Dustin Secor transferred ownership of 85,950,000 series A preferred shares with a par value $.00001 per share to three parties as follows: Richard Shykora; 28,650,000, Agnes Cruz; 28,650,000 and Les Eveneshen: 28,650,000. This assignment was effective as of April 29, 2013.
During the quarter ending April 30, 2013, the Company issued a stock dividend consisting of a total of 526,709 series C preferred shares with a par value of $.0001 per share, to a selected number of common stock shareholders.
During the quarter ending July 31, 2013, the Company converted debt to equity, issuing 107,545 series C preferred shares with a par value $.00001 per share pursuant to the Dustin Secor note agreement.
Item XXI Issuer’s Certifications. I, William White, certify that: 1. I have reviewed this annual information statement of Andiamo Corporation, a Nevada Corporation; 2. Based on my knowledge, this disclosure statement does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this disclosure statement; and 3. Based on my knowledge, the financial statements, and other financial information included or incorporated by reference in this disclosure statement, fairly present in all material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this disclosure statement. Dated: November 26, 2014 /s/ William White William White Title: CEO
3. Counsel – Ken Bart Bart and Associates LLC 8400 East Prentice Avenue Suite 1500 Greenwood Village, CO 80111 United States 720-226-7511 kbart@kennethbartesq.com
1
3
Andiamo Corp (ANDI) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...
Continue Reading
Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...
Continue Reading
In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...
Continue Reading
Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...
Continue Reading
The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...
Continue Reading
A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...
Continue Reading
IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...
Continue Reading
Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...
Continue Reading
Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...
Continue Reading
Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...
Continue Reading
Top 5 Most Recently Viewed Articles
Introduction to the New Battery Charger for Electric Vehicles In a world where electric vehicles (EVs) are becoming more prevalent, the quest for convenience and reliability in charging options has led to the creation of an exciting new product. An inventive mind has developed a portable battery charger designed specifically for electric cars, addressing the significant...
Continue Reading
The growth of the future value is not sufficient to invest in rental property, particularly in a market place such as Calgary where the economic cycles and population dynamics may affect the results. By computing the returns on the rental property, investors are able to know whether a property will be able to produce sustainable returns as they accumulate long te
Continue Reading
BioCardia's Anticipated Earnings Report BioCardia (NASDAQ: BCDA) is gearing up for its next quarterly earnings announcement. Investors are keen to hear the results as they look to gain insights into the company's performance and future expectations. Expected Earnings Per Share Current estimates suggest that BioCardia will report an earnings per share (EPS) of...
Continue Reading
President Trump's Impact During His Initial Month As President Trump's new term unfolds, impactful events are shaping his administration's direction. The first month has been marked by significant developments, highlighted by the Senate's confirmation of Kash Patel as the Director of the FBI. This move is seen as a pivotal moment, emphasizing a commitment to addressing...
Continue Reading
Eramet Revenue Decline in Q3 2025 Eramet has reported a decline in its adjusted turnover for the third quarter of 2025, which totaled €720 million. This marks a 10% decrease compared to the same quarter in 2024. The decrease primarily stems from significant external factors affecting sales and market conditions. Safety and CSR Achievements Despite facing a challenging...
Continue Reading